CPA Welcomes FDA Proposal to Expose Hidden Foreign Suppliers in America’s Drug Supply Chain
For years, the most critical link in our drug supply chain — the upstream chemistry — has been invisible to our own regulators. A medicine finished in Europe is not necessarily a European medicine…
Read the full articleYou might also wanna read
Senate bill seeks to curb US reliance on China in drug industry
Bipartisan US senators on Wednesday unveiled legislation aimed at increasing transparency around foreign influence in the pharmaceutical ind
Europe–US new drug manufacturing outsourcing gap widens, reveals GlobalData
Contract manufacturing facilities located in the US and Europe provide biopharma companies with strategic options to diversify supply chains
FDA moves to expose hidden foreign drug factories, strengthen domestic production in sweeping rule proposal
New registration rules and a tracking website aim to reveal where active ingredients in medicines actually come from
Senate bill seeks to curb US reliance on China in drug industry
US lawmakers are pushing for more scrutiny of Chinese investment in pharmaceuticals and biotechnology, as Washington’s strategic competition
Why the West has an uphill task challenging China in pharmaceutical ingredients
From rare earth elements to commercial drones, Washington has become all too familiar with the strongest weapons in Beijing’s manufacturing
Leviathan Waking
Imagine that there were no Food and Drug Administration (FDA), but there remained a large pharmaceutical sector, similar in size and scope t
Comments
Sign in to join the conversation.
No comments yet. Be the first.